Welcome to our dedicated page for Marathon Pete SEC filings (Ticker: MPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking refining margins across Marathon Petroleum鈥檚 13-facility network shouldn鈥檛 require combing through hundreds of pages of technical disclosure. Yet each 10-K buries crack-spread data, environmental liabilities, and pipeline tariff details behind dense accounting language. That鈥檚 the pain point investors voice most often.
Our platform solves it. Stock Titan delivers AI-powered summaries that translate every Marathon Petroleum annual report 10-K simplified, Marathon Petroleum quarterly earnings report 10-Q filing, and Marathon Petroleum 8-K material events explained into plain English within minutes of hitting EDGAR. AG真人官方-time alerts flag Marathon Petroleum Form 4 insider transactions real-time, letting you monitor executive stock sales the same moment they鈥檙e filed. Need quick context? Just ask: 鈥渦nderstanding Marathon Petroleum SEC documents with AI鈥� and our system highlights which refinery turnaround or MPLX dropdown drives the numbers.
Every filing type is covered: proxy statements for Marathon Petroleum proxy statement executive compensation, insider forms for Marathon Petroleum insider trading Form 4 transactions, and 8-Ks for unplanned outages鈥攁ll searchable, all linked to concise analytics. Use the data to compare quarter-over-quarter crack spreads, spot Marathon Petroleum executive stock transactions Form 4 before earnings, or dive into segment performance with our Marathon Petroleum earnings report filing analysis. Complex disclosures become actionable intelligence, enabling energy analysts, credit desks, and retail investors to act decisively without wading through footnotes.
Bath & Body Works, Inc. (BBWI) 鈥� Form 4
On 08/01/2025, CFO Eva C. Boratto reported an automatic share withholding tied to the vesting of restricted stock units. Transaction code 鈥淔鈥� denotes shares withheld solely to satisfy taxes; no open-market trade occurred. The issuer retained 6,533 common shares at an implied value of $28.17 per share. After the withholding, Boratto鈥檚 direct ownership is 118,426 shares of BBWI common stock.
No derivative positions were reported and the filing shows no change to the executive鈥檚 economic exposure beyond the tax-related share surrender.
Marathon Petroleum (MPC) Q2 2025 10-Q highlights:
- Sales & other operating revenues fell 11% YoY to $33.8 bn; six-month total down 8% to $65.3 bn.
- Net income attributable to MPC dropped 20% to $1.22 bn, or $3.96 diluted EPS; first-half profit slid 53% to $1.14 bn ($3.68 EPS).
- Segment EBITDA: Refining & Marketing 鈭�6.5% to $1.89 bn; Midstream +1% to $1.64 bn; Renewable Diesel loss narrowed to $19 m.
- Operating cash flow YTD contracted 46% to $2.58 bn; capex $1.35 bn and share buy-backs $1.75 bn absorbed liquidity.
- Cash & equivalents fell to $1.67 bn (-48% from YE-24); total debt rose to $29.0 bn after new MPC ($2 bn) and MPLX ($2 bn) issuances.
- Weighted-average diluted shares fell to 307 m (-12% YoY); $6.03 bn remains under $10 bn repurchase authorizations.
- Effective tax rate ~14%; management assessing implications of the newly-enacted 鈥淥ne Big Beautiful Bill Act.鈥�
Lower refining margins and higher interest expense drove earnings weakness, partly offset by resilient Midstream results and aggressive capital returns.
On August 5, 2025, Marathon Petroleum Corporation (NYSE: MPC) filed a Form 8-K under Item 2.02 to furnish, rather than file, its press release announcing financial results for the quarter ended June 30, 2025. The earnings release is attached as Exhibit 99.1 and is incorporated by reference only to the extent expressly stated in future filings. No quantitative results, guidance, or financial statements appear in the Form 8-K itself. A cover-page Inline XBRL file is listed as Exhibit 104. The report was signed by Executive Vice President & Chief Financial Officer John J. Quaid.
The Vanguard Group filed Amendment No. 12 to Schedule 13G for Myriad Genetics, Inc. (MYGN) covering the period ended 30 Jun 2025.
- Beneficial ownership: 9,257,493 common shares, representing 10.04 % of outstanding stock.
- Voting power: 0 shares sole; 145,939 shares shared.
- Dispositive power: 9,003,551 shares sole; 253,942 shares shared.
- Filed under Rule 13d-1(b) as an investment adviser (IA); the holding is reported as passive and in the ordinary course of business.
- Crossing the 10 % threshold designates Vanguard as a 10 % beneficial owner, increasing disclosure and potential Section 16 obligations.
The filing signals continued, sizable institutional ownership but does not indicate any intent to influence control. Certification signed by Ashley Grim, Head of Global Fund Administration, on 29 Jul 2025.
Marathon Petroleum Corp. (MPC) 鈥� Form 4 insider transaction
Director Kim K.W. Rucker sold 7,392 MPC common shares on 07 Jul 2025 at an average price of $175 per share, generating proceeds of roughly $1.3 million. The trade was executed under a pre-arranged Rule 10b5-1 plan adopted on 19 May 2024, indicating it was scheduled in advance.
Following the sale, Rucker鈥檚 direct holdings declined to 18,944.271 shares. The filing also notes the inclusion of 105.405 dividend-reinvested shares previously unreported.
The transaction represents approximately 28% of the director鈥檚 prior stake, but is immaterial relative to MPC鈥檚 ~480 million shares outstanding. No derivative transactions were reported.
Marathon Petroleum Corporation (MPC) has filed a Form 144 indicating a proposed sale of 7,392 common shares through Fidelity Brokerage Services on 3 July 2025 at the NYSE. Based on the quoted aggregate market value of $1.29 million, the implied price per share is approximately $175. The shares represent roughly 0.0024 % of the 307.2 million shares outstanding disclosed in the form. The shares were originally acquired via restricted-stock vesting on 1 April 2019 and are being sold for the account of an unidentified insider. No other sales were reported in the past three months, and no additional remarks, 10b5-1 plan information, or adverse disclosures accompany the notice.